Article
Targeting Leukemic Stem Cells in Chronic Myeloid Leukemia: Is It Worth the Effort?
30 Jun 2021
Abstract excerpt
Chronic myeloid leukemia (CML) is a classical example of stem cell cancer since it arises in a multipotent hematopoietic stem cell upon the acquisition of the t(9;22) chromosomal translocation, that converts it into a leukemic stem cell (LSC). The resulting BCR-ABL1 fusion gene encodes a deregulated tyrosine kinase that is recognized as the disease driver. Therapy with tyrosine kinase inhibitors (TKIs) eliminates...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
